Ownership and insider activity for Inspira Technologies OXY B.H.N. Ltd. (IINN): insider transactions, US Senate and House trading disclosures and shares outstanding. Track how corporate insiders and politicians are trading the stock.
Inspira Technologies Oxy B.H.N. Ltd., a specialty medical device company, engages in the research, development, manufacturing, and marketing of proprietary life support technologies for the treatment of acute respiratory failure in Israel. It offers INSPIRA ART100, a life support system used in procedures requiring cardiopulmonary bypass for six hours or less.
Price
| Price | $1.05 |
| Market Cap | $25M |
| Exchange | NASDAQ |
| Country | IL |
Balance Sheet (10y)
| Year | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $8000 | $96000 | $496000 | $23.7M | $6.8M | $5.0M | $5.1M | $3.3M |
| Short-term Investments | 0 | 0 | 0 | 0 | $7.1M | $2.3M | $668000 | 0 |
| Receivables | 0 | $51000 | $188000 | $210000 | 0 | $432000 | 0 | 0 |
| Inventory | -$3000 | $34949 | 0 | $336000 | -$279000 | 0 | $444000 | $735000 |
| Total Current Assets | $11000 | $182000 | $684000 | $24.5M | $14.5M | $7.8M | $6.8M | $4.4M |
| Property, Plant & Equipment | 0 | $192000 | $303000 | $1.4M | $1.5M | $1.5M | $1.3M | $930000 |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Assets | $11000 | $374000 | $987000 | $25.9M | $16.0M | $9.3M | $8.1M | $5.3M |
| Accounts Payable | 0 | $74000 | $3000 | $93000 | $152000 | $198000 | $154000 | $107000 |
| Short-term Debt | 0 | $4.7M | $399000 | $3.5M | $294000 | $1.8M | $1.9M | $1.4M |
| Total Current Liabilities | $40000 | $5.0M | $951000 | $4.3M | $1.7M | $3.0M | $3.4M | $2.8M |
| Long-term Debt | 0 | 0 | $1.6M | $302000 | $398000 | $588000 | 0 | 0 |
| Total Liabilities | $40000 | $5.0M | $2.7M | $5.5M | $3.2M | $3.6M | $3.7M | $3.0M |
| Retained Earnings | -$33000 | -$4.6M | -$11.8M | -$28.8M | -$44.2M | -$55.5M | -$66.6M | -$79.8M |
| Total Equity | -$29000 | -$4.6M | -$1.7M | $20.4M | $13.6M | $5.7M | $4.3M | $2.3M |
| Total Debt | 0 | $4.8M | $2.3M | $1.5M | $1.5M | $878000 | $2.5M | $1.6M |
| Net Debt | -$8000 | $4.7M | $1.8M | -$22.3M | -$12.4M | -$6.5M | -$3.3M | -$1.7M |
| Working Capital | -$29000 | -$4.8M | -$267000 | $20.2M | $12.8M | $4.8M | $3.4M | $1.6M |
Financial Health
| Debt / Equity | 0.21 |
| Current Ratio | 1.56 |
| Piotroski F-Score | 2 |
| Altman Z-Score | -23.62 |
Profitability
| Return on Equity | -569.09% |
| Return on Invested Capital | -326.40% |
| Return on Assets | -247.52% |
| Gross Margin | 0.69% |
| Operating Margin | 2503.46% |
| Net Margin | -2213.84% |
Related companies: BFRI · ENSC · FEED · HSCS · ISPC · PTPI · RPID
Explore sector: Healthcare · Medical - Devices
More sections of IINN: Overview · Financials · Valuation · Statistics · Estimates · Technical · News · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks